Skip to main content
Screener/Healthcare/Biotechnology

CGON — CG Oncology, Inc. Common stock

NASDAQ
$66.11-0.14 (-0.21%)
Mid CapHealthcareFastest GrowingLow Beta
$23.65
$75.50
$63.75
$66.60
EPS (TTM)$-2.34
P/E Ratio-31.47
Dividend Yield—
Market Cap$5.33B
Volume389K
Prev Close$66.25
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$1.1M-$60.2M$-0.71-173.5%-5558.8%
Q4 '25$2.3M-$41.3M$-0.52-25.5%-1779.0%
Q3 '25$1.7M-$43.8M$-0.575.3%-2629.5%
Q2 '25$0-$41.4M$-0.54——
Q1 '25$52K-$34.5M$-0.45100.0%-66253.8%
Q4 '24$456K-$31.8M$-0.49100.0%-6973.2%
Q3 '24$43K-$20.4M$-0.30100.0%-47453.5%
Q2 '24$111K-$18.9M$-0.28100.0%-17028.8%
Get Your Daily Market Recap